Annals of the New York Academy of Sciences

Journal

Publication Venue For

  • Protective role of HO-1 against acute kidney injury caused by cutaneous exposure to arsenicals. 2020
  • Halogen exposure injury in the developing lung. 2020
  • Circulating and tissue biomarkers as predictors of bromine gas inhalation. 2020
  • MicroRNA-mediated inflammation and coagulation effects in rats exposed to an inhaled analog of sulfur mustard. 2020
  • Hyaluronan and halogen-induced airway hyperresponsiveness and lung injury. 2020
  • Cutaneous lewisite exposure causes acute lung injury. 2020
  • New research directions on disparities in obesity and type 2 diabetes.  1461:5-24. 2020
  • The expanding functional roles and signaling mechanisms of adhesion g protein–coupled receptors.  1456:5-25. 2019
  • Learning from the past: Reflections on recently completed myasthenia gravis trials.  1412:5-13. 2018
  • Piecing together the puzzle of pancreatic islet adaptation in pregnancy.  1411:120-139. 2018
  • Muscle–bone interactions: Movement in the field of mechano–humoral coupling of muscle and bone.  1402:10-17. 2017
  • Disease drivers of aging.  1386:45-68. 2016
  • Biological and environmental hazards associated with exposure to chemical warfare agents: arsenicals.  1378:143-157. 2016
  • Chlorine-induced cardiopulmonary injury.  1374:159-167. 2016
  • Emerging targets for treating sulfur mustard–induced injuries.  1374:123-131. 2016
  • Role of heme in bromine-induced lung injury.  1374:105-110. 2016
  • Significant life extension by ten percent dietary restriction.  1363:11-17. 2016
  • FCRL regulation in innate-like B cells.  1362:110-116. 2015
  • The role of evolutionarily conserved germ-line DH sequence in B-1 cell development and natural antibody production.  1362:48-56. 2015
  • Function and regulation of primary cilia and intraflagellar transport proteins in the skeleton.  1335:78-99. 2015
  • Bone safety of low-dose glucocorticoids in rheumatic diseases.  1318:55-64. 2014
  • Circadian clocks, brain function, and development.  1306:43-67. 2013
  • The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis.  1281:16-35. 2013
  • Biomarker development for myasthenia gravis.  1275:101-106. 2012
  • Conjectures on some curious connections among social status, calorie restriction, hunger, fatness, and longevity.  1264:1-12. 2012
  • Population shifts and the future of stroke: Forecasts of the future burden of stroke.  1268:14-20. 2012
  • Barrett's esophagus: Surgical treatments.  1232:175-195. 2011
  • Anthropogenic impacts on marine ecosystems in Antarctica.  1223:82-107. 2011
  • Chemosensitization of tumors by resveratrol.  1215:150-160. 2011
  • New approaches for treating staphylococcal biofilm infections.  1241:104-121. 2011
  • Animal models of reproductive aging: What can they tell us?.  1204:123-126. 2010
  • Humanized mouse models of Cooley's anemia: Correct fetal-to-adult hemoglobin switching, disease onset, and disease pathology.  1202:45-51. 2010
  • Inflammation precedes the development of human malignant mesotheliomas in a SCID mouse xenograft model.  1203:7-14. 2010
  • Role of HIF-1α in skeletal development.  1192:322-326. 2010
  • Organization, integration, and assembly of genetic and epigenetic regulatory machinery in nuclear microenvironments: Implications for biological control in cancer.  1155:4-14. 2009
  • Single molecule probing of SNARE proteins by atomic force microscopy.  1152:113-120. 2009
  • Genes and molecules that can potentiate or attenuate psychostimulant dependence: Relevance of data from animal models to human addiction.  1141:76-95. 2008
  • Rules of evidence for clinical trials: The science of finding the truth?.  1132:233-237. 2008
  • Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone.  1132:344-347. 2008
  • Oxygen sensing and osteogenesis.  1117:1-11. 2007
  • Mitochondria damage checkpoint, aging, and cancer.  1067:182-190. 2006
  • Molecular approaches to the role of the microbiota in inflammatory bowel disease.  1072:39-51. 2006
  • NFATc1: A novel anabolic therapeutic target for osteoporosis.  1068:564-567. 2006
  • Opposite regulation of cocaine-induced intracellular signaling and gene expression by dopamine D1 and D3 receptors.  1074:1-12. 2006
  • Pathogenesis of osteopenia/osteoporosis induced by highly active anti-retroviral therapy for AIDS.  1068:297-308. 2006
  • Role of cellular compartmentation in the metabolic response to stress: Mechanistic insights from computational models.  1080:120-139. 2006
  • Effects of extracellular calcium on fASIC1 currents.  1048:331-336. 2005
  • Regulation of cardiac energetics: Role of redox state and cellular compartmentation during ischemia.  1047:259-270. 2005
  • Early upregulation of T cell IL-10 production plays an important role in oral tolerance induction.  1029:319-20. 2004
  • Early upregulation of T cell IL-10 production plays an important role in oral tolerance induction.  1029:319-320. 2004
  • Genome-wide analysis of signal transducers and regulators of mitochondrial dysfunction in Saccharomyces cerevisiae.  1011:284-298. 2004
  • Isolated lymphoid follicles can function as sites for induction of mucosal immune responses.  1029:44-57. 2004
  • Mitochondrial dysfunction is a common phenotype in aging and cancer.  1019:260-264. 2004
  • Oral tolerance in humans: Failure to suppress an existing immune response by oral antigen administration.  1029:299-309. 2004
  • Oral tolerance in humans: failure to suppress an existing immune response by oral antigen administration.  1029:299-309. 2004
  • Role of Cdk5 in drug abuse and plasticity.  1025:335-344. 2004
  • Antibody repertoire in a mouse with a simplified DH locus: The D-limited mouse.  987:262-265. 2003
  • Molecular mechanism of serial VH gene replacement.  987:270-273. 2003
  • Putative targets of CNS melanocortin receptor activity.  994:211-217. 2003
  • Mass and thermal diffusivity algorithms: Reduced algorithms for mass and thermal diffusivity determinations.  974:146-156. 2002
  • The influence of gravity on composition uniformity and microstructure in immiscible Al-In alloys.  974:102-109. 2002
  • Dysregulation of [Ca2+]i in OK-PTH cells expressing a mesangial cell Na+/Ca2+ exchanger isoform from Dahl/Rapp salt-sensitive rats.  976:338-341. 2002
  • Enhanced susceptibility of a Na+/Ca2+ exchanger isoform from mesangial cells of salt-sensitive Dahl/Rapp rats to oxidative stress inactivation.  976:342-344. 2002
  • Glutathione in defense and signaling: Lessons from a small thiol.  973:488-504. 2002
  • Identification of chronic cocaine-induced gene expression through dopamine D1 receptors by using cDNA microarrays.  965:1-9. 2002
  • Neural mechanisms for the control of vergence eye movements.  956:264-272. 2002
  • Effects of phytoestrogens and synthetic combinatorial libraries on aromatase, estrogen biosynthesis, and metabolism.  948:51-66. 2001
  • Inflamm-aging. An evolutionary perspective on immunosenescence.  908:244-254. 2000
  • Probing the role of the dopamine D1 receptor in psychostimulant addiction.  914:13-21. 2000
  • The proopiomelanocortin system in cutaneous neuroimmunomodulation. An introductory overview..  885. 1999
  • ACTH production in C57BL/6 mouse skin.  885:448-450. 1999
  • Desensitization of nicotinic receptors in the central nervous system.  868:620-623. 1999
  • Differential temporal and spatial expression of POMC mRNA and of the production of POMC peptides during the murine hair cycle.  885:427-429. 1999
  • Distribution of group III mGluRs in rat basal ganglia with subtype-specific antibodies.  868:531-534. 1999
  • Proopiomelanocortin and the immune-neuroendocrine connection.  885:161-172. 1999
  • UV light and MSH receptors.  885:100-116. 1999
  • Cutaneous immunomodulation and coordination of skin stress responses by α-melanocyte-stimulating hormone A.  840:381-394. 1998
  • Bilateral integration of sensorimotor signals during pedaling.  860:513-516. 1998
  • Cocaine-inhibited neuronal differentiation in NGF-induced PC12 cells and altered C-fos expression are reversed by C-fos antisense oligonucleotide.  846:427-430. 1998
  • Effects of antimetabolites to glucose and fatty acids on galanin-1 receptor mRNA levels in the hypothalamic paraventricular and supraoptic nuclei.  863:430-431. 1998
  • Experimental models to study molecular mechanisms underlying intestinal disease. Proceedings of Symposium Intestinal Plasticity in Health and Disease.  859:85-95. 1998
  • Experimental models to study molecular mechanisms underlying intestinal inflammation.  859:85-95. 1998
  • RBC adhesion to cremaster endothelum in mice with abnormal hemoglobin is increased by topical endotoxin.  850:391-393. 1998
  • CDR3 fingerprinting of immunoglobulin kappa light chains expressed in rheumatoid arthritis. Evidence of antigenic selection or dysregulation of gene rearrangement in B cells.  815:423-426. 1997
  • Fat and energy balance.  827:431-448. 1997
  • Immunoglobulin J chain. An early differentiation marker of human B cells.  815:111-113. 1997
  • Induction of tolerance in humans. Effectiveness of oral and nasal immunization routes.  778:194-201. 1996
  • Induction of tolerance in humans: Effectiveness of oral and nasal immunization routes.  778:194-201. 1996
  • Oral antigen delivery via a multiple emulsion system enhances oral tolerance.  778:156-62. 1996
  • Oral-antigen delivery by way of a multiple emulsion system enhances oral tolerance.  778:156-162. 1996
  • Role of γδ T cells in the regulation of mucosal IgA response and oral tolerance.  778:55-63. 1996
  • Systemic and mucosal protective immunity to pneumococcal surface protein A.  797:118-126. 1996
  • The role of Th1 and Th2 cells for mucosal IgA responses.  778:64-71. 1996
  • A Complementary Method to Radioligand‐Mediated Autoradiography for Localizing Adrenergic, Alpha‐2 Receptor‐Producing Cells.  763:222-242. 1995
  • Analysis of DHQ52 Gene Segment Transcription and Rearrangement During B‐Cell Development in Human Fetal Bone Marrow.  764:228-230. 1995
  • Analysis of Immunoglobulin Gamma Heavy Chains from Rheumatoid Arthritis Synovium Evidence of Antigen‐Driven Selection.  764:450-460. 1995
  • Analysis of immunoglobulin gamma heavy chains from rheumatoid arthritis synovium.  764:450-452. 1995
  • Cord Blood Transplantation and the Potential for Gene Therapy: Gene Transduction Using a Recombinant Adeno‐Associated Viral Vector.  770:105-115. 1995
  • Development of the Mouse B‐Cell Repertoire.  764:207-221. 1995
  • Developmental Regulation of the Human Antibody Repertoire.  764:242-260. 1995
  • Effects of Okadaic Acid on Calcitriol‐and Phorbol Ester‐Induced Expression and Phosphorylation of Osteopontin in Mouse JB6 Epidermal Cells.  760:24-34. 1995
  • Human B‐Cell Development.  764:1-8. 1995
  • In Situ Hybridization Analysis of Immunoglobulin VH Gene Family Expression in Rheumatoid Arthritis.  764:453-456. 1995
  • Potentiation of B‐Cell Antigen Receptor‐mediated Signal Transduction by the Heterologous src Family Protein Tyrosine Kinase, src.  766:214-215. 1995
  • Structure—Function Studies of Human Monoclonal Antibodies to Pneumococcus Type 3 Polysaccharide.  764:370-373. 1995
  • The Human Poliovirus Receptor: Receptor‐Virus Interaction and Parameters of Disease Specificity.  753:19-36. 1995
  • T‐Cell Repertoires in Health and Disease.  756:53-65. 1995
  • Vβ17 T‐Cell Receptor Peptide Vaccine: Results of a Phase I Dose‐Finding Study in Patients with Rheumatoid Arthritis.  756:211-214. 1995
  • Cross‐Reactive Protection Eliciting Epitopes of Pneumococcal Surface Protein A.  730:361-363. 1994
  • Mouse Virulence Gene A (mviA+) Is a Pleiotropic Regulator of Gene Expression in Salmonella typhimurium.  730:295-296. 1994
  • Shared ligands and receptors as a molecular mechanism for communication between the immune and neuroendocrine systems.  741:292-298. 1994
  • Application of X‐Ray Crystallographic Methods in the Design of Purine Nucleoside Phosphorylase Inhibitors.  685:237-247. 1993
  • Effects of Nonsteroidal Antiinflammatory Drugs on Bone Loss in Chronic Inflammatory Disease.  696:292-302. 1993
  • Saliva as a Manifestation of the Common Mucosal Immune System.  694:184-194. 1993
  • Effect of a VH81X‐Expressing IgM Antibody on Early B‐Cell Development.  651:160-161. 1992
  • Identification and Cloning of Rabbit CD5.  651:78-81. 1992
  • Idiotypic Regulation of Development of the B‐Cell Repertoire.  651:336-345. 1992
  • Opioid Modulation of Immunoglobulin Production by Lymphocytes Isolated from Peyer's Patches and Spleen.  650:125-127. 1992
  • Perinatally Derived Antiidiotypic Antibodies from the Antipolyfructosan Immune Response: Molecular Analysis of Idiotype Regulation.  651:316-318. 1992
  • The Fetal Omentum in Mice and Humans: A Site Enriched for Precursors of CD5 B Cells Early in Development.  651:10-20. 1992
  • Pro‐opiomelanocortin Expression and Potential Function of Pro‐opiomelanocortin Products during Induced Hair Growth in Mice.  642:459-461. 1991
  • Survey of Thymic Hormone Effects on Physical and Immunological Parameters in C57BL/6NNia Mice of Different Ages.  621:239-255. 1991
  • Bidirectional Communication between the Neuroendocrine and Immune Systems Common Hormones and Hormone Receptors.  579:17-27. 1990
  • Biochemical and Cellular Characteristics of Suppressin. A Novel Pituitary‐derived Inhibitor of Neuroendocrine and Immune Cell Proliferation.  594:393-395. 1990
  • Characteristics of Lymphocyte‐derived Proopiomelanocortin‐related mRNA.  594:382-384. 1990
  • Characterization of cDNA and Genomic Clones for the α Subunit of Human Prolyl 4‐Hydroxylase.  580:473-476. 1990
  • Corticotropin‐releasing Hormone Enhances Murine Natural Killer Cell Activity through an Opioid‐Mediated Pathway.  594:371-373. 1990
  • Detection of Transforming Growth Factor‐β2 and β3 Messenger Ribonucleic Acids in the Chicken.  593:313-313. 1990
  • Growth Hormone Production and Growth Hormone Releasing Hormone Receptors in the Rat Immune System.  594:432-434. 1990
  • Novel Pharmacological Strategies in the Treatment of Life‐Threatening Cytomegalovirus Infections: Clinical Experience with Continuous Infusion 9‐(1,3‐Dihydroxy‐2‐Propoxymethyl) Guanine.  616:452-460. 1990
  • Role of Sympathetic Innervation in Cardiac Development in Oculo.  588:120-130. 1990
  • Chinese Hamster Ovary Cell Mutants Deficient in an Anion Exchanger Functionally Similar to Erythroid Band 3.  574:109-112. 1989
  • Differential Expression of Fv‐1 in Fibroblasts Derived from Embryonal Carcinoma Cells.  567:280-281. 1989
  • Immune Neuroendocrine Interactions: Implications for Reproductive Physiology.  564:261-266. 1989
  • Augmentation of Natural Immunity and Regulation of Tumor Growth by Conditioning.  521:29-42. 1988
  • Functional Analysis of Cd2, cd4, and cd8 in t‐Cell Activation.  532:199-206. 1988
  • Indirect Evidence of the Nature of the Antigen Receptor on Antigen‐Specific Suppressor Cells: Monoclonal Antibodies Against CAT‐Specific Suppressor Factors Can Alter the Capacity of H‐2 Specific Suppressor Cells to Regulate the Response of CTL to Allogeneic Target Cells.  546:204-206. 1988
  • Natural History and Pathogenesis of Neonatal Herpes Simplex Virus Infections.  549:103-117. 1988
  • Opioid Receptors on Murine Splenocytes: Possible Coupling to K+ Channels.  540:694-697. 1988
  • Opioid receptors on murine splenocytes. Possible coupling to K+ channels..  540:694-697. 1988
  • Rat Astrocyte Proliferation by Human B‐Cell Growth Factors.  540:392-395. 1988
  • Regulation of Self‐Tolerance to Insulin.  546:238-239. 1988
  • A Possible Cause of Myasthenia Gravis: Idiotypic Networks Involving Bacterial Antigens.  505:461-471. 1987
  • Influence of Conditioned Natural Immunity on Tumor Growth.  496:637-646. 1987
  • Leukocyte Production of Endorphins.  496:192-195. 1987
  • Regulation of Natural Immunity (NK Activity) by Conditioning.  496:545-552. 1987
  • Bronchoalveolar Lavage Cell Analysis in Sarcoidosis: A Comparison of Lymphocyte Counts and Clinical Course.  465:678-684. 1986
  • Role of Microtubules in the Formation of Carotenoid Droplet Aggregate in Goldfish Xanthophores.  466:887-894. 1986
  • Studies of the Effects of Y Chromosome Factors on the Expression of Autoimmune Disease.  475:200-218. 1986
  • The Role of Sinoaortic and Cardiopulmonary Baroreceptor Reflex Arcs in Nociception and Stress‐Induced Analgesia.  467:385-401. 1986
  • Abnormal Accumulation of Basement Membrane (Type IV) and Cytoskeletal (Type V) Collagens in the Strictures of Crohn's Disease: The Probable Role of Intestinal Smooth Muscle Cells.  460:439-442. 1985
  • Biologic Regulation of Na/H Antiporter Activity in a Cultured Kidney Cell Line: Effects of Parathyroid Hormone (PTH).  456:451-453. 1985
  • Regulation of the Activity of the Na+‐H+ Antiporter in Brush‐Border Membrane Vesicles from the Proximal Tubule.  456:229-231. 1985
  • Small Proteins Affect Na+ Gradient‐Dependent d‐Glucose Transport in Isolated Renal Brush‐Border Membrane Vesicles.  456:101-104. 1985
  • ANTIBACTERIAL PROPERTIES OF MILK: IgA‐PEROXIDASE‐LACTOFERRIN INTERACTIONS.  409:848-850. 1983
  • AUGMENTATION OF IgA RESPONSES AND CARIES IMMUNITY BY ORAL ADJUVANTS.  409:851-852. 1983
  • Analysis of Idiotypic Heterogeneity in the Anti‐α1–3 Dextran and Anti‐Phosphorylcholine Responses Using Monoclonal Anti‐Idiotype Antibodies.  418:151-169. 1983
  • DEFICIENT IgA SYNTHESIS VIEWED IN THE CONTEXT OF NORMAL DEVELOPMENT OF IgA B‐CELLS.  409:461-468. 1983
  • DISTRIBUTION OF IgA1 AND IgA2 SUBCLASSES IN HUMAN TISSUE: CORRELATION WITH THE PRESENCE OF J‐CHAIN.  409:803-805. 1983
  • EFFECT OF DIMETHYL SULFOXIDE ON CHEMOTAXIS OF PHAGOCYTIC CELLS.  411:321-323. 1983
  • FUNCTION AND BIOSYNTHESIS OF POLYMERIC IgA.  409:292-306. 1983
  • Helper T cell activity in intestinal lamina propria.  409:230-230. 1983
  • IDENTIFICATION OF A NONADHERENT ACCESSORY CELL IN MURINE PEYER'S PATCHES.  409:880-881. 1983
  • IMMUNE REGULATION OF SUPPRESSION IN OFFSPRING OF ORALLY TOLERIZED MICE.  409:888-889. 1983
  • IgA HYBRIDOMAS TO CELL‐SURFACE COMPONENTS OF PATHOGENIC BACTERIA.  409:794-796. 1983
  • IgA RHEUMATOID FACTOR: EVIDENCE FOR INDEPENDENT EXPRESSION AT LOCAL SITES OF TISSUE INFLAMMATION.  409:258-272. 1983
  • IgA‐MEDIATED HEPATOBILIARY CLEARANCE OF BACTERIAL ANTIGENS.  409:871-872. 1983
  • MURINE PEYER'S PATCH T‐HELPER CELL CLONES THAT PREFERENTIALLY SUPPORT IgA RESPONSES.  409:829-830. 1983
  • PEYER'S PATCH ACCESSORY CELLS BEAR I‐A.  409:819-821. 1983
  • REGULATION OF IgA SUBCLASSES IN POKEWEED MITOGEN STIMULATED CULTURES.  409:797-798. 1983
  • SELECTIVE HEPATOBILIARY TRANSPORT OF MONOCLONAL IgG, BUT NOT IgM ANTI‐IDIOTYPIC ANTIBODIES, BY IgA.  409:859-860. 1983
  • Structural Correlates of Idiotypy in the Arsonate System.  418:48-64. 1983
  • THE IgA RESPONSE: INDUCTIVE ASPECTS, REGULATORY CELLS, AND EFFECTOR FUNCTIONS.  409:48-71. 1983
  • T‐HELPER CELL ACTIVITY IN INTESTINAL LAMINA PROPRIA.  409:230-237. 1983
  • Alzheimer's Disease, Down's Syndrome, and Aging: The Genetic Approach.  396:3-13. 1982
  • THE SELECTIVE ROLE OF MEMBRANE IgG IN THE ANTIGEN‐INDUCED INHIBITION OF HUMAN IN VITRO ANTIBODY PRODUCTION.  392:416-417. 1982
  • ACTION OF RETINOIDS AND PHORBOL ESTERS ON CELL GROWTH AND THE BINDING OF EPIDERMAL GROWTH FACTOR.  359:200-217. 1981
  • INTERACTION OF HUMAN ANTIBODY AND MURINE MONOCLONAL ANTIBODY WITH MUSCLE ACETYLCHOLINE RECEPTOR.  377:143-157. 1981
  • SPECIFIC AND NONSPECIFIC ALTERATIONS IN MEMBRANE MICROVISCOSITY INDUCED BY RETINOIDS IN EMBRYONAL CARCINOMA AND FIBROBLAST CELLS.  359:398-400. 1981
  • IMMUNE INTERFERON: SOME PROPERTIES AND FUNCTIONS.  350:130-144. 1980
  • ROLE OF NONSPECIFIC AND SPECIFIC SUPPRESSOR FACTORS IN IMMUNITY.  332:336-344. 1979
  • ALERTNESS, LEVEL OF ACTIVITY, AND PURPOSIVE MOVEMENT FOLLOWING SOMATOSENSORY DEAFFERENTATION IN MONKEYS.  290:348-365. 1977
  • International Standard Serial Number (issn)

  • 0077-8923
  • Electronic International Standard Serial Number (eissn)

  • 1749-6632